A Case of Disseminated and Fulminant Plasmacytomas That Developed during Bortezomib Treatment

Publisher： Karger

E-ISSN： 1662-6575|4|1|101-105

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.4, Iss.1, 2011-02, pp. : 101-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unusual Discordant Responses in Two Multiple Myeloma Patients during Bortezomib Treatment

By  

Oncology Research and Treatment, Vol. 31, Iss. 1-2, 2008-01 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

Treatment of acute antibody‐mediated rejection using bortezomib: a case report

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 86-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 259-264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe Heart Failure after Bortezomib Treatment in a Patient with Multiple Myeloma: A Case Report and Review of the Literature

By  

Acta Haematologica, Vol. 128, Iss. 4, 2012-09 ,pp. : 244-247

Karger

Access to resources Recommend Favorite

Etretinate Treatment in Disseminated Porokeratosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 15, Iss. 5, 1988-10 ,pp. : 440-444

John Wiley & Sons Inc

Access to resources Recommend Favorite